Biological Activity
GSK481 is a novel benzoxazepinone (BOAz) series of RIP1 inhibitors. Receptor Interacting Protein Kinase 1 (RIP1) has been implicated as a key contributor to inflammation through the regulation of programmed necrosis. Inhibition of this kinase has been shown to hinder cell necrotic death, thereby establishing RIP1 as a viable target for the potential treatment of multiple inflammatory diseases.
Targets
RIP1 | ||||
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 26.5 mL | 132.49 mL | 264.98 mL |
0.5 mM | 5.3 mL | 26.5 mL | 53 mL |
1 mM | 2.65 mL | 13.25 mL | 26.5 mL |
5 mM | 0.53 mL | 2.65 mL | 5.3 mL |
*The above data is based on the productmolecular weight 377.39. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A12615 |
---|---|
Actions | Inhibitor |
M. Wt | 377.39 |
Formula | C21H19N3O4 |
Solubility | DMSO |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1622849-58-4 |
Synonyms | GSK 481, GSK-481 |
SMILES | O=C(C1=NOC(CC2=CC=CC=C2)=C1)N[[email protected]]3COC4=CC=CC=C4N(C)C3=O |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy GSK481 | GSK481 Supplier | purchase | cost | manufacturer | order | distributor | buy 1622849-58-4| 1622849-58-4 Supplier | purchase 1622849-58-4 | 1622849-58-4 cost | 1622849-58-4 manufacturer | order 1622849-58-4 | 1622849-58-4 distributor